ICI profits up 53pc

Published October 29, 2019
"The results are driven by improved operational performance, along with exchange gain," ICI says in a statement. — Photo courtesy Mechatech website/File
"The results are driven by improved operational performance, along with exchange gain," ICI says in a statement. — Photo courtesy Mechatech website/File

KARACHI: ICI Pakistan Limited unveiled results for the first quarter ended Sept 30, posting an after-tax-profit at Rs836 million, up 53 per cent from the same quarter earlier year.

The figures were on consolidated basis, including results of the company’s subsidiaries: ICI Pakistan PowerGen Limited, Cirin Pharmaceutical Ltd and NutriCo Morinaga Ltd.

The company wrote in a statement “the results are driven by improved operational performance, along with exchange gain in comparison to the exchange loss same period last year, particularly offset by higher finance costs during the period under review due to higher interest rates.”

On a standalone basis, the PAT at Rs926m and EPS at Rs10.03 were higher by 41pc year-on-year (YoY). Net turnover increased 9pc to Rs14.516bn over same period last year.

FFC reports Rs12.4bn profit

Fauji Fertiliser Company Ltd (FFC) declared financial results for 9MCY19 reporting profit-after-tax at Rs12.4 billion translating into earnings per share of Rs9.80, up 46pc over Rs8.5bn (EPS Rs6.70) same period last year.

On a quarterly basis, the PAT during 3QCY19 stood at Rs3.6bn (EPS of Rs2.80), down 6pc from Rs3.8bn (EPS Rs2.99) during the same period last year.

Along with the results, the company announced an interim cash dividend at Rs2.20 per share taking 9MCY19 payout to Rs7.55 per share.

Atlas Honda declares Rs6.5 cash dividend

Atlas Honda Limited announced financial results for second quarter ended Sept 30, earning PAT at Rs570m and EPS of Rs4.60 against PAT at Rs747m and EPS of Rs6.02 in the same quarter earlier year.

Analysts commented that earnings were down by 24pc year-on-year due to depletion in gross profit margin by two percentage points in this quarter.

Sales decreased 2.6pc to Rs18.5bn, from Rs19.0bn. The company announced interim cash dividend at Rs6.50 per share.

GSK earnings soar 71pc

GlaxoSmithKline Ltd (GSK) reported financial results for 3Q2019, recording PAT at Rs924 million and EPS at Rs2.90 against PAT of Rs541m and EPS of Rs1.70 in same period last year.

Earnings grew by 71pc YoY due to increase of 21pc in other income at Rs434m against Rs359m in the same quarter previous year.

Published in Dawn, October 29th, 2019

Follow Dawn Business on Twitter, LinkedIn, Instagram and Facebook for insights on business, finance and tech from Pakistan and across the world.

Opinion

Editorial

Weathering the storm
Updated 29 Apr, 2024

Weathering the storm

Let 2024 be the year when we all proactively ensure that our communities are safeguarded and that the future is secure against the inevitable next storm.
Afghan repatriation
29 Apr, 2024

Afghan repatriation

COMPARED to the roughshod manner in which the caretaker set-up dealt with the issue, the elected government seems a...
Trying harder
29 Apr, 2024

Trying harder

IT is a relief that Pakistan managed to salvage some pride. Pakistan had taken the lead, then fell behind before...
Return to the helm
Updated 28 Apr, 2024

Return to the helm

With Nawaz Sharif as PML-N president, will we see more grievances being aired?
Unvaxxed & vulnerable
Updated 28 Apr, 2024

Unvaxxed & vulnerable

Even deadly mosquito-borne illnesses like dengue and malaria have vaccines, but they are virtually unheard of in Pakistan.
Gaza’s hell
Updated 28 Apr, 2024

Gaza’s hell

Perhaps Western ‘statesmen’ may moderate their policies if a significant percentage of voters punish them at the ballot box.